AMWL - American Well Corp Stock Price, Fair Value and News

0.53USD0.00 (0.00%)Delayed as of 25 Apr 2024, 09:59 am ET

Market Summary

USD0.530.00

Delayedas of 25 Apr 2024, 09:59 am

0.00%

AMWL Stock Price

View Fullscreen

AMWL RSI Chart

AMWL Valuation

Market Cap

152.9M

Price/Earnings (Trailing)

-0.23

Price/Sales (Trailing)

0.59

EV/EBITDA

0.34

Price/Free Cashflow

-1.03

AMWL Price/Sales (Trailing)

AMWL Profitability

EBT Margin

-259.69%

Return on Equity

-145.64%

Return on Assets

-114.65%

Free Cashflow Yield

-97.15%

AMWL Fundamentals

AMWL Revenue

Revenue (TTM)

259.0M

Rev. Growth (Yr)

-10.8%

Rev. Growth (Qtr)

14.14%

AMWL Earnings

Earnings (TTM)

-676.1M

Earnings Growth (Yr)

21.62%

Earnings Growth (Qtr)

65.06%

Breaking Down AMWL Revenue

52 Week Range

0.522.74

(Low)(High)

Last 7 days

3.9%

Last 30 days

-36.1%

Last 90 days

-53.9%

Trailing 12 Months

-74.3%

How does AMWL drawdown profile look like?

AMWL Financial Health

Current Ratio

4.79

AMWL Investor Care

Shares Dilution (1Y)

5.19%

Diluted EPS (TTM)

-2.39

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	277.0M	274.9M	267.6M	259.0M
2022	259.4M	263.7M	270.7M	277.2M
2021	249.2M	240.8M	240.5M	252.8M
2020	173.0M	197.1M	221.2M	245.3M
2019	0	0	131.4M	148.9M
2018	0	0	0	114.0M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of American Well Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	knight kurt	sold	-4,753	0.7721	-6,157	chief operating officer
Apr 01, 2024	mcneice paul francis	sold	-587	0.7721	-761	chief accounting officer
Apr 01, 2024	gotlib phyllis	sold	-5,320	0.7721	-6,891	president, international
Apr 01, 2024	shepardson robert	sold	-5,844	0.7721	-7,569	chief financial officer
Mar 08, 2024	mcneice paul francis	sold	-5,572	1.0285	-5,418	chief accounting officer
Mar 01, 2024	paunovich vukasin	sold	-33,976	1.0714	-31,712	evp, enterprise platforms
Mar 01, 2024	gotlib phyllis	sold	-38,688	1.0714	-36,110	president, international
Mar 01, 2024	shepardson robert	sold	-73,179	1.0714	-68,303	chief financial officer
Mar 01, 2024	knight kurt	sold	-41,513	1.0714	-38,747	chief operating officer
Feb 23, 2024	paunovich vukasin	sold	-274,369	1.0917	-251,323	evp, enterprise platforms

Which funds bought or sold AMWL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-62.74	-26,000	6,000	-%
Apr 23, 2024	CGC Financial Services, LLC	unchanged	-	-53.00	62.00	-%
Apr 23, 2024	WASHINGTON TRUST Co	unchanged	-	-686	819	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	40,754	189,763	-%
Apr 22, 2024	Raymond James Financial Services Advisors, Inc.	unchanged	-	-12,753	15,219	-%
Apr 22, 2024	SAPIENT CAPITAL LLC	unchanged	-	-112,688	134,485	-%
Apr 18, 2024	Oak Thistle LLC	new	-	45,977	45,977	0.04%
Apr 18, 2024	Hexagon Capital Partners LLC	unchanged	-	-543	649	-%
Apr 18, 2024	Capital Advisors, Ltd. LLC	new	-	1,000	1,000	-%
Apr 10, 2024	Perennial Advisors, LLC	new	-	8,107	8,107	-%

Are Funds Buying or Selling AMWL?

Are funds buying AMWL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AMWL

No. of Funds

Unveiling American Well Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	caledonia (private) investments pty ltd	6.79%	17,297,672	SC 13G/A
Feb 13, 2024	vanguard group inc	5.19%	13,207,174	SC 13G/A
Feb 12, 2024	schoenberg ido	6.1%	16,551,623	SC 13G/A
Feb 09, 2024	senvest management, llc	9.2%	23,529,964	SC 13G/A
Jan 25, 2024	blackrock inc.	8.4%	21,512,979	SC 13G/A
Feb 14, 2023	caledonia (private) investments pty ltd	7.15%	17,330,824	SC 13G/A
Feb 13, 2023	schoenberg ido	6.1%	15,851,706	SC 13G/A
Feb 10, 2023	senvest management, llc	6.72%	16,295,094	SC 13G/A
Feb 09, 2023	vanguard group inc	8.91%	21,606,125	SC 13G/A
Feb 03, 2023	blackrock inc.	8.1%	19,697,878	SC 13G/A

Recent SEC filings of American Well Corp

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	PRE 14A	PRE 14A
Apr 04, 2024	8-K	Current Report
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Apr 01, 2024	144	Notice of Insider Sale Intent
Apr 01, 2024	144	Notice of Insider Sale Intent
Mar 12, 2024	4	Insider Trading

Peers (Alternatives to American Well Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	0.31%	-0.92%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	-0.92%	38.85%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-14.21%	-7.01%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-2.46%	13.22%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.12%	9.99%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-1.51%	52.05%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-6.67%	17.96%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.23%	9.23%	34.28	4.13	6.06%	9.17%
ACHC	6.6B	2.9B	-6.62%	-3.50%	-303.23	2.24	12.20%	-107.93%
AMN	2.2B	3.8B	-8.18%	-34.26%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.68%	1.59%	33.78	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-7.02%	-15.70%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	4.49%	59.95%	-6.76	0.42	6.74%	20.73%
BEAT	54.0M	-	-6.82%	-	-3.69	-	-	-12.94%
AMS	19.1M	21.3M	14.29%	7.64%	35.87	0.9	8.00%	-62.25%

American Well Corp News

Latest updates

American Well Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2018Q4
Revenue	14.1%	70,677,000	61,922,000	62,447,000	64,001,000	79,233,000	69,209,000	64,516,000	64,232,000	72,750,000	62,223,000	60,217,000	57,599,000	60,432,000	62,551,000	68,568,000	53,714,000	44,229,000	34,744,000	-
Operating Expenses	-37.8%	127,632,000	205,282,000	156,953,000	461,323,000	144,076,000	140,333,000	133,920,000	134,714,000	120,173,000	117,673,000	97,752,000	96,337,000	109,993,000	126,838,000	156,400,000	79,465,000	-	60,493,000	-
S&GA Expenses	7.0%	21,801,000	20,379,000	21,554,000	22,726,000	23,260,000	18,493,000	18,721,000	21,154,000	21,263,000	16,370,000	14,789,000	13,732,000	15,117,000	13,758,000	12,346,000	13,874,000	-	11,309,000	-
R&D Expenses	-4.9%	26,347,000	27,715,000	25,842,000	25,923,000	27,685,000	36,254,000	37,067,000	37,481,000	33,777,000	27,399,000	22,378,000	23,040,000	26,564,000	25,275,000	17,637,000	14,936,000	-	13,602,000	-
EBITDA Margin	-1.1%	-2.48	-2.45	-2.15	-2.05	-0.88	-0.85	-0.83	-0.73	-0.64	-0.70	-0.74	-0.92	-0.88	-0.83	-0.75	-0.46	-0.55	-0.34	-0.41
Income Taxes	-51.2%	547,000	1,122,000	716,000	1,475,000	-160,000	95,000	461,000	-332,000	-334,000	-5,454,000	103,000	309,000	309,000	78,000	252,000	-	-	-392,000	-
Earnings Before Taxes	64.0%	-48,783,000	-135,382,000	-92,174,000	-396,382,000	-60,829,000	-69,887,000	-68,640,000	-70,374,000	-47,206,000	-55,832,000	-37,311,000	-38,677,000	-49,339,000	-64,032,000	-87,524,000	-24,904,000	-	-24,463,000	-
EBT Margin	-1.5%	-2.60	-2.56	-2.25	-2.15	-0.97	-0.95	-0.92	-0.81	-0.71	-0.75	-0.79	-0.96	-0.92	-0.87	-0.79	-0.51	-0.60	-0.37	-0.46
Net Income	65.1%	-47,656,500	-136,414,000	-93,515,000	-398,509,000	-60,801,500	-70,084,000	-69,652,000	-70,253,000	-47,346,000	-51,494,000	-38,136,000	-39,805,000	-49,109,500	-63,081,000	-88,220,000	-25,224,000	-21,989,000	-24,071,000	-
Net Income Margin	-1.3%	-2.61	-2.58	-2.27	-2.16	-0.98	-0.95	-0.91	-0.80	-0.70	-0.74	-0.79	-0.96	-0.92	-0.86	-0.79	-0.52	-0.59	-0.38	-0.46
Free Cashflow	-9.5%	-41,672,000	-38,051,000	-39,646,000	-29,166,000	-36,236,000	-50,922,000	-43,198,000	-62,259,000	-45,261,000	-29,162,000	-26,386,000	-41,287,000	-24,587,000	-31,069,000	-26,779,000	-33,347,000	-15,517,000	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																		(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Assets	-7.1%	590	635	772	851	1,218	1,232	1,298	1,362	1,446	1,484	1,292	1,322	1,377	1,414	1,109	805	500	-
Current Assets	-8.0%	450	489	535	588	627	657	707	753	827	855	1,036	1,061	1,113	1,144	-	-	224	300
Cash Equivalents	16.5%	372	319	161	113	539	333	257	177	746	790	975	896	943	956	233	124	139	54.00
Inventory	-15.1%	7.00	8.00	9.00	8.00	9.00	8.00	8.00	8.00	8.00	9.00	9.00	9.00	9.00	8.00	-	-	3.00	3.00
Net PPE	-0.7%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	2.00	2.00	3.00	3.00	3.00	4.00	4.00	-	-	3.00	3.00
Goodwill	-	-	-	79.00	107	435	425	434	441	443	444	194	194	194	194	-	-	194	127
Liabilities	-5.0%	110	115	128	136	134	127	138	153	185	187	100	107	130	117	120	122	125	118
Current Liabilities	-4.9%	94.00	99.00	110	116	114	105	116	129	142	127	91.00	98.00	121	107	-	-	107	88.00
Shareholder's Equity	-7.6%	464	502	644	714	1,064	1,105	1,161	1,209	1,261	1,298	1,193	1,215	1,246	1,297	-	-	-	-
Retained Earnings	-2.8%	-1,757	-1,709	-1,572	-1,479	-1,082	-1,020	-950	-881	-811	-762	-708	-668	-582	-532	-	-	-357	-270
Additional Paid-In Capital	0.6%	2,235	2,222	2,204	2,183	2,160	2,134	2,109	2,077	2,054	2,038	1,877	1,860	1,841	1,828	-	-	50.00	37.00
Shares Outstanding	0.5%	288	287	284	281	274	277	274	268	254	259	249	244	99.00	51.00	43.00	42.00	41.00	41.00
Minority Interest	-8.4%	16.00	17.00	18.00	19.00	20.00	20.00	21.00	21.00	22.00	22.00	21.00	21.00	22.00	22.00	-	-	26.00	27.00
Float	-	-	-	515	-	-	-	868	-	2,400	-	-	-	5,200	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2018Q4
Cashflow From Operations	-9.4%	-41,576	-37,991	-39,628	-29,148	-35,946	-50,978	-43,208	-62,191	-44,923	-29,224	-26,251	-41,139	-24,530	-30,112	-25,729	-32,093	-	-	-
Share Based Compensation	-24.9%	12,679	16,882	21,677	21,008	19,256	20,821	15,523	12,075	12,053	12,388	10,726	8,642	11,842	34,420	67,638	4,458	-	-	-
Cashflow From Investing	-51.7%	94,339	195,359	88,873	-397,739	239,700	124,930	123,031	-499,291	-338	-156,464	99,865	-2,696	29,920	-101,011	-1,306	5,640	-	-	-
Cashflow From Financing	-100.0%	-	896	-305	1,556	417	1,500	2,224	-7,753	1,217	1,045	5,191	-1,699	-20,191	854,845	135,896	12,566	-	-	-
Buy Backs	-100.0%	-	586	-585	-1.00	-	-	-	-	1,050	2,360	11,613	15.00	19,151	18,254	5.00	158	-	-	-

AMWL Income Statement

2023-12-31

Consolidated Statements of Operations And Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue
($3,859, $4,544 and $12,045 from related parties, respectively)	$ 259,047	$ 277,190	$ 252,789
Costs and operating expenses:
Costs of revenue, excluding depreciation and amortization of intangible assets	164,287	160,422	148,474
Research and development	105,827	138,487	106,594
Sales and marketing	86,460	81,628	66,154
General and administrative	126,645	146,353	94,624
Depreciation and amortization expense	31,492	26,153	16,089
Goodwill Impairment	436,479
Total costs and operating expenses	951,190	553,043	431,935
Loss from operations	(692,143)	(275,853)	(179,146)
Interest income and other income (expense), net	19,422	6,123	120
Loss before benefit (expense) from income taxes and loss from equity method investment	(672,721)	(269,730)	(179,026)
(Expense) benefit from income taxes	(3,860)	(64)	5,376
Loss from equity method investment	(2,590)	(2,278)	(3,132)
Net loss	(679,171)	(272,072)	(176,782)
Net loss attributable to non-controlling interest	(4,007)	(1,643)	(448)
Net loss attributable to American Well Corporation	$ (675,164)	$ (270,429)	$ (176,334)
Net loss per share attributable to common stockholders, basic	$ (2.38)	$ (0.99)	$ (0.69)
Net loss per share attributable to common stockholders, diluted	$ (2.38)	$ (0.99)	$ (0.69)
Weighted-average common shares outstanding, basic	284,256,743	274,249,749	254,068,942
Weighted-average common shares outstanding, diluted	284,256,743	274,249,749	254,068,942
Net loss	$ (679,171)	$ (272,072)	$ (176,782)
Other comprehensive income (loss), net of tax:
Unrealized loss on available-for-sale investments			(85)
Foreign currency translation	1,319	(10,616)	(6,565)
Comprehensive loss	(677,852)	(282,688)	(183,432)
Less: Comprehensive loss attributable to non-controlling interest	(4,007)	(1,643)	(448)
Comprehensive loss attributable to American Well Corporation	$ (673,845)	$ (281,045)	$ (182,984)

AMWL Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 372,038	$ 538,546
Accounts receivable ($1,626 and $2,597, from related parties and net of allowances of $2,291 and $1,884, respectively)	54,146	58,372
Inventories	6,652	8,737
Deferred contract acquisition costs	2,262	1,394
Prepaid expenses and other current assets	14,484	19,567
Total current assets	449,582	626,616
Restricted cash	795	795
Property and equipment, net	572	1,012
Goodwill	0	435,279
Intangibles assets, net	120,248	134,980
Operating lease right-of-use asset	10,453	13,509
Deferred contract acquisition costs, net of current portion	4,792	3,394
Other assets	2,083	1,972
Investment in minority owned joint venture (Note 2)	1,180
Total assets	589,705	1,217,557
Current liabilities:
Accounts payable	4,864	7,236
Accrued expenses and other current liabilities	38,988	54,258
Operating lease liability, current	3,580	3,057
Deferred revenue ($1,286 and $1,665 from related parties, respectively)	46,365	49,505
Total current liabilities	93,797	114,056
Other long-term liabilities	1,425	1,574
Operating lease liability, net of current portion	8,206	11,787
Deferred revenue, net of current portion ($0 and $10 from related parties, respectively)	6,091	6,289
Total liabilities	109,519	133,706
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares issued or outstanding as of December 31, 2023 and as of December 31, 2022
Common stock, $0.01 par value; 1,000,000,000 Class A shares authorized, 255,542,545 and 244,193,727 shares issued and outstanding, respectively; 100,000,000 Class B shares authorized, 27,390,397 shares issued and outstanding, respectively; 200,000,000 Class C shares authorized 5,555,555 issued and outstanding as of December 31, 2023 and as of December 31, 2022	2,879	2,766
Additional paid-in capital	2,234,768	2,160,108
Accumulated other comprehensive income (loss)	(15,650)	(16,969)
Accumulated deficit	(1,757,778)	(1,082,028)
Total American Well Corporation stockholders’ equity	464,219	1,063,877
Non-controlling interest	15,967	19,974
Total stockholders’ equity	480,186	1,083,851
Total liabilities and stockholders’ equity	$ 589,705	$ 1,217,557

About American Well Corp

American Well Corporation operates digital care delivery enablement platform in the United States and internationally. Its platform connects and enables providers, insurers, patients, and innovators to deliver access for quality care. The company's products offer urgent care; scheduled visits; acute behavioral health; telestroke; comprehensive behavioral health; ED triage; pediatrics; end-stage renal disease and dialysis; and retail health, school health, and home settings. Its application offers telehealth urgent care; primary care; chronic care; digital therapy; teledermatology; manage Medicaid; behavior health; online nutrition counselling; sleep; women's health; employee assistance program therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, hospital TV kits, and telehealth tablets. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

CEO	Dr. Ido Schoenberg M.D.
WEBSITE	https://amwell.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1123

American Well Corp Frequently Asked Questions

What is the ticker symbol for American Well Corp? What does AMWL stand for in stocks?

AMWL is the stock ticker symbol of American Well Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of American Well Corp (AMWL)?

As of Wed Apr 24 2024, market cap of American Well Corp is 152.9 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMWL stock?

You can check AMWL's fair value in chart for subscribers.

What is the fair value of AMWL stock?

You can check AMWL's fair value in chart for subscribers. The fair value of American Well Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of American Well Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMWL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is American Well Corp a good stock to buy?

The fair value guage provides a quick view whether AMWL is over valued or under valued. Whether American Well Corp is cheap or expensive depends on the assumptions which impact American Well Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMWL.

What is American Well Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, AMWL's PE ratio (Price to Earnings) is -0.23 and Price to Sales (PS) ratio is 0.59. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMWL PE ratio will change depending on the future growth rate expectations of investors.